LUKE JOHNSON: Open Payments
NPI 1063009983 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,252 in 28 payments from 16 companies in 2025. Trend: 2023 $500 · 2024 $856 · 2025 $2,252
Food & beverage: $2,238Travel & lodging: $14
| Company | Payments | Amount |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | 2 | $262 |
| Novo Nordisk Inc | 3 | $246 |
| Lilly USA, LLC | 2 | $195 |
| Gilead Sciences, Inc. | 4 | $195 |
| SCPHARMACEUTICALS INC. | 2 | $150 |
| AstraZeneca Pharmaceuticals LP | 4 | $142 |
| Alnylam Pharmaceuticals Inc. | 1 | $138 |
| Bolton Medical Inc | 2 | $135 |
| SANOFI US SERVICES INC. | 1 | $132 |
| Globus Medical, Inc. | 1 | $130 |
Products named: VOQUEZNA, FUROSCIX, ONPATTRO, AYVAKIT, Senza, VIVITROL, KEVZARA, XIFAXAN.
Industry payments across TX — which companies pay providers there.
